Frontlight ResearchEarly access
Taking people in FranceNo phase
Combined hepatitis B, hepatitis C and HIV testing for drug users
Looks at drug users' acceptance of hepatitis and HIV screening.
Key facts
- Who runs it
- University Hospital, Limoges
- Where
- Limoges, FranceSee the site
- Trial code
- Registry title
- Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
- Status
- Recruiting
- People taking part
- 1,500 people, planned
- Started
- 24 May 2017
- Expected to end
- 14 Feb 2030
- Type of study
- Observational
- Record updated
- 4 May 2022
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who visit a non-conventional care site "outside the walls" or are sent there by a care professional, and who agree to take part.
- Age
- 18 years and older
- Sex
- Men and women can join.
Main reasons for not taking part
- People who do not agree to take part in the research cannot join.
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Adult 18 and over
- Patient frequenting an unconventional structure "outside the walls" or referred by a professional in the care sector
- Patient who agreed to participate to the research
Who cannot take part
- Patient doesn't agree to participate to the research
Where in France
- CHU LimogesLimoges, FranceContact: FRANCOIS Sandrine, PhDTaking people
About the trial
What the trial wants to find out
The principle is to propose dedicated monthly screening days bringing together the health personnel involved (hepatologist, addictologist, nurse in charge of the program, addictology nurse and social worker) and to propose appropriate management for each situation assessed.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Facilities "Outside the Walls" Using the Dual Screening Method TROD (Rapid Diagnostic Tests) and FibroScan
- Plain-language title
- Combined hepatitis B, hepatitis C and HIV testing for drug usersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 4 May 2022